<DOC>
	<DOCNO>NCT01075477</DOCNO>
	<brief_summary>This observational study assess execution , efficacy safety treatment MabThera patient rheumatoid arthritis . Data patient receive MabThera accord local treatment guideline collect 29 month . Target sample size 100-200 patient .</brief_summary>
	<brief_title>An Observational Study Patients With Rheumatoid Arthritis Treated With MabThera ( Rituximab )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>adult patient , &gt; /= 18 year age rheumatoid arthritis treatment rituximab unable/unwilling give inform consent data collection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>